Surgical Science Sweden AB (publ) (STO:SUS)
Sweden
· Delayed Price · Currency is SEK 32.04
-0.56 (-1.72%)
At close: Mar 6, 2026
STO:SUS Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 992.34 | 884.09 | 882.85 | 802.54 | 366.78 | Upgrade
|
| Revenue Growth (YoY) | 12.25% | 0.14% | 10.01% | 118.81% | 249.98% | Upgrade
|
| Cost of Revenue | 334.67 | 286.19 | 269.97 | 271.02 | 100.84 | Upgrade
|
| Gross Profit | 657.68 | 597.9 | 612.88 | 531.52 | 265.94 | Upgrade
|
| Selling, General & Admin | 298.7 | 252.38 | 240.02 | 201.88 | 117.26 | Upgrade
|
| Research & Development | 222.11 | 196.11 | 181.57 | 172.79 | 65.71 | Upgrade
|
| Other Operating Expenses | 2.39 | 5.09 | 2.14 | - | - | Upgrade
|
| Operating Expenses | 523.19 | 453.58 | 423.73 | 374.66 | 182.97 | Upgrade
|
| Operating Income | 134.48 | 144.32 | 189.15 | 156.86 | 82.98 | Upgrade
|
| Interest Expense | -6.2 | -0.75 | -0.64 | -0.54 | -0.51 | Upgrade
|
| Interest & Investment Income | 15.4 | 23.96 | 64.73 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -37.7 | -4.23 | 15.04 | 5.68 | -6.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.05 | -5.21 | -0.02 | 46.17 | 18.06 | Upgrade
|
| EBT Excluding Unusual Items | 106.04 | 158.09 | 268.26 | 208.17 | 94.5 | Upgrade
|
| Merger & Restructuring Charges | -5.9 | - | - | - | -28.7 | Upgrade
|
| Pretax Income | 100.14 | 158.09 | 268.26 | 208.17 | 65.8 | Upgrade
|
| Income Tax Expense | 33.32 | 26.45 | 34.29 | 20.2 | -20.44 | Upgrade
|
| Net Income | 66.82 | 131.65 | 233.97 | 187.97 | 86.25 | Upgrade
|
| Net Income to Common | 66.82 | 131.65 | 233.97 | 187.97 | 86.25 | Upgrade
|
| Net Income Growth | -49.24% | -43.73% | 24.47% | 117.95% | 452.66% | Upgrade
|
| Shares Outstanding (Basic) | 51 | 51 | 51 | 51 | 42 | Upgrade
|
| Shares Outstanding (Diluted) | 51 | 51 | 51 | 51 | 43 | Upgrade
|
| Shares Change (YoY) | - | 0.17% | 0.05% | 19.32% | 24.14% | Upgrade
|
| EPS (Basic) | 1.31 | 2.58 | 4.59 | 3.70 | 2.03 | Upgrade
|
| EPS (Diluted) | 1.31 | 2.58 | 4.59 | 3.69 | 2.02 | Upgrade
|
| EPS Growth | -49.24% | -43.79% | 24.39% | 82.67% | 348.89% | Upgrade
|
| Free Cash Flow | 68.12 | 131.12 | 227.84 | 120.14 | 35.21 | Upgrade
|
| Free Cash Flow Per Share | 1.33 | 2.57 | 4.47 | 2.36 | 0.82 | Upgrade
|
| Gross Margin | 66.27% | 67.63% | 69.42% | 66.23% | 72.51% | Upgrade
|
| Operating Margin | 13.55% | 16.32% | 21.43% | 19.55% | 22.62% | Upgrade
|
| Profit Margin | 6.73% | 14.89% | 26.50% | 23.42% | 23.52% | Upgrade
|
| Free Cash Flow Margin | 6.86% | 14.83% | 25.81% | 14.97% | 9.60% | Upgrade
|
| EBITDA | 194.65 | 169.65 | 212.15 | 177.47 | 99 | Upgrade
|
| EBITDA Margin | 19.62% | 19.19% | 24.03% | 22.11% | 26.99% | Upgrade
|
| D&A For EBITDA | 60.17 | 25.33 | 23 | 20.61 | 16.02 | Upgrade
|
| EBIT | 134.48 | 144.32 | 189.15 | 156.86 | 82.98 | Upgrade
|
| EBIT Margin | 13.55% | 16.32% | 21.43% | 19.55% | 22.62% | Upgrade
|
| Effective Tax Rate | 33.27% | 16.73% | 12.78% | 9.70% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.